Main > EAR NOSE THROAT (ENT) > Tumor Necrosis Factor AntAgonist > MAb Type TNF AntAgonist. > Etanercept; InflixiMAb Etc. > Hearing Loss. Presbycusis. > Patent. > Claims > Claim 1: Hearing Loss Treat Adm.: > TNF AntAgonist: Etanercept for > Inflammation Redn. Claim 10: > Hearing Loss Treat. Adm.: > TNF AntAgonist: InflixiMAb for > Inflammation Redn. Claim 16:



Inflammation Redn. Claim 16:'s subsections
Presbycusis Treat.: TNF AntAgonist

Inflammation Redn. Claim 16:'s products
This section has no products